Detalles de la búsqueda
1.
Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant.
Immunity
; 54(6): 1276-1289.e6, 2021 06 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33836142
2.
Global patterns of antigen receptor repertoire disruption across adaptive immune compartments in COVID-19.
Proc Natl Acad Sci U S A
; 119(34): e2201541119, 2022 08 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-35943978
3.
The effect of Omicron breakthrough infection and extended BNT162b2 booster dosing on neutralization breadth against SARS-CoV-2 variants of concern.
PLoS Pathog
; 18(10): e1010882, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36191037
4.
TMPRSS2 promotes SARS-CoV-2 evasion from NCOA7-mediated restriction.
PLoS Pathog
; 17(11): e1009820, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34807954
5.
Modular capsid decoration boosts adenovirus vaccine-induced humoral immunity against SARS-CoV-2.
Mol Ther
; 30(12): 3639-3657, 2022 12 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35949171
6.
ACE2 expression in adipose tissue is associated with cardio-metabolic risk factors and cell type composition-implications for COVID-19.
Int J Obes (Lond)
; 46(8): 1478-1486, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35589964
7.
Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settings.
PLoS Pathog
; 16(9): e1008817, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32970782
8.
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study.
Lancet Oncol
; 22(6): 765-778, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33930323
9.
Single dose of BNT162b2 mRNA vaccine against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) induces neutralising antibody and polyfunctional T-cell responses in patients with chronic myeloid leukaemia.
Br J Haematol
; 194(6): 999-1006, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34085278
10.
BNT162b2 COVID-19 and ChAdOx1 nCoV-19 vaccination in patients with myelodysplastic syndromes.
Haematologica
; 107(5): 1181-1184, 2022 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35045695
11.
Endogenous antibody responses in REGN-COV2-treated SARS-CoV-2-infected individuals.
Oxf Open Immunol
; 4(1): iqac012, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36844257
12.
Broad and potent neutralizing antibodies are elicited in vaccinated individuals following Delta/BA.1 breakthrough infection.
mBio
; 14(5): e0120623, 2023 Oct 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37747187
13.
Antibody levels following vaccination against SARS-CoV-2: associations with post-vaccination infection and risk factors in two UK longitudinal studies.
Elife
; 122023 01 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-36692910
14.
A neutralizing epitope on the SD1 domain of SARS-CoV-2 spike targeted following infection and vaccination.
Cell Rep
; 40(8): 111276, 2022 08 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-35981534
15.
Broad Neutralization of SARS-CoV-2 Variants, Including Omicron, following Breakthrough Infection with Delta in COVID-19-Vaccinated Individuals.
mBio
; 13(2): e0379821, 2022 04 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-35297676
16.
ChAdOx1 nCoV-19 vaccine elicits monoclonal antibodies with cross-neutralizing activity against SARS-CoV-2 viral variants.
Cell Rep
; 39(5): 110757, 2022 05 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35477023
17.
SARS-CoV-2 host-shutoff impacts innate NK cell functions, but antibody-dependent NK activity is strongly activated through non-spike antibodies.
Elife
; 112022 05 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35587364
18.
Humoral and cellular immunogenicity to a second dose of COVID-19 vaccine BNT162b2 in people receiving methotrexate or targeted immunosuppression: a longitudinal cohort study.
Lancet Rheumatol
; 4(1): e42-e52, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34778846
19.
Preclinic group education sessions reduce waiting times and costs at public pain medicine units.
Pain Med
; 12(1): 59-71, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21087401
20.
The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study.
Lancet Rheumatol
; 3(9): e627-e637, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34258590